Purpose of reviewDrug-induced muscle disorders are important causes of morbidity, but the risk–benefit profile of the incriminated drugs must be put into perspective. This review highlights some recent advances on statin-induced and antiretroviral drug-induced myopathies and calls attention to some
No takes yet. Share an insight, caveat, or question.
Thomas Klopstock (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: